Regeneron Pharmaceuticals, Inc. $REGN Stock Position Lifted by AE Wealth Management LLC

robot
Abstract generation in progress

AE Wealth Management LLC significantly increased its stake in Regeneron Pharmaceuticals (NASDAQ: REGN) by 36.7% in the fourth quarter, bringing its total to 5,474 shares valued at $4.23 million. This move comes as Regeneron reported stronger-than-expected quarterly earnings and revenue, and raised its quarterly dividend. Despite mixed market views and recent insider selling, institutional ownership remains high at 83.31%, and analysts maintain a “Moderate Buy” consensus rating for the stock.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin